213 related articles for article (PubMed ID: 25103881)
1. A phenome-guided drug repositioning through a latent variable model.
Bisgin H; Liu Z; Fang H; Kelly R; Xu X; Tong W
BMC Bioinformatics; 2014 Aug; 15(1):267. PubMed ID: 25103881
[TBL] [Abstract][Full Text] [Related]
2. PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.
Jang G; Lee T; Hwang S; Park C; Ahn J; Seo S; Hwang Y; Yoon Y
J Biomed Inform; 2018 Nov; 87():96-107. PubMed ID: 30268842
[TBL] [Abstract][Full Text] [Related]
3. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
4. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets.
Wang YY; Cui C; Qi L; Yan H; Zhao XM
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698
[TBL] [Abstract][Full Text] [Related]
5. Exploring the associations between drug side-effects and therapeutic indications.
Wang F; Zhang P; Cao N; Hu J; Sorrentino R
J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
[TBL] [Abstract][Full Text] [Related]
6. Investigating drug repositioning opportunities in FDA drug labels through topic modeling.
Bisgin H; Liu Z; Kelly R; Fang H; Xu X; Tong W
BMC Bioinformatics; 2012; 13 Suppl 15(Suppl 15):S6. PubMed ID: 23046522
[TBL] [Abstract][Full Text] [Related]
7. Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.
Su EW
Methods Mol Biol; 2019; 1903():61-72. PubMed ID: 30547436
[TBL] [Abstract][Full Text] [Related]
8. Literature-based prediction of novel drug indications considering relationships between entities.
Jang G; Lee T; Lee BM; Yoon Y
Mol Biosyst; 2017 Jun; 13(7):1399-1405. PubMed ID: 28581007
[TBL] [Abstract][Full Text] [Related]
9. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
10. A survey of current trends in computational drug repositioning.
Li J; Zheng S; Chen B; Butte AJ; Swamidass SJ; Lu Z
Brief Bioinform; 2016 Jan; 17(1):2-12. PubMed ID: 25832646
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records.
Robinson JR; Denny JC; Roden DM; Van Driest SL
Clin Transl Sci; 2018 Mar; 11(2):112-122. PubMed ID: 29148204
[No Abstract] [Full Text] [Related]
12. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Jang D; Lee S; Lee J; Kim K; Lee D
J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
14. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
Wang R; Li S; Cheng L; Wong MH; Leung KS
BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
[TBL] [Abstract][Full Text] [Related]
15. Prediction of drug indications based on chemical interactions and chemical similarities.
Huang G; Lu Y; Lu C; Zheng M; Cai YD
Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813
[TBL] [Abstract][Full Text] [Related]
16. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
Le DH; Nguyen-Ngoc D
Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
18. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning for diabetes based on 'omics' data mining.
Zhang M; Luo H; Xi Z; Rogaeva E
PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning using drug-disease vectors based on an integrated network.
Lee T; Yoon Y
BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
